After 12 years, more than 1600 and over 522,000 page views form 167 different countries, the HEDS Blog is closing down.  We have decided to concentrate our efforts on other platforms such as Twitter, our webinars and our podcasts. Read further on to find out where you can follow us.  Regent Court (the home of the HEDS Blog)   So while it was fun while it lasted – except for the threat of legal action in relation to one post about one particularly ludicrous cost-effectiveness model that will remain nameless (unless you buy me a drink at ISPOR) – we shall b ..read more

The Health Economics and Decision Science (HEDS) Section are currently advertising for a Research Programme Coordinator to the National Institute for Health and Care Excellence (NICE) funded Decision Support Unit (DSU) and The Policy Research Unit in Economic Evaluation of Health and Social Care Interventions (EEPRU). ScHARR, Regent Court Job Reference Number: UOS035392 Contract Type: Fixed-term for 28 months Working Pattern: Part-time, working 24.5 hours per week, days of working to be agreed Faculty: Faculty of Medicine Department: Health Economics and D ..read more

The newsletter you've all been waiting for!  HEDS Newsletter Autumn/Winter 2022 The Autumn/Winter 2022 issue of the HEDS Newsletter is now available and includes: International development of a new measure of Health and Wellbeing, HEDS hosts the 100th Health Economists' Study Group (HESG) meeting, A new framework to identify quality of mental healthcare, And the latest publications by HEDS staff  Read it online here ..read more

Here is our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield. Many of these are currently in press, you can find much of our work in its open access form via our institutional repository. Find them here Hnynn Si, P.E., Gair, R., Barnes, T., Dunn, L., Lee, S., Ariss, S., Walters, S.J., Wilkie, M. and Fotheringham, J., 2022. Symptom burden according to dialysis day of the week in three times a week haemodialysis patients. PloS one, 17(9), https://doi.org/10.1371/journal.pone.0274599 Mayland, C. R., Sunderland, K ..read more

We are currently advertising for a Research Assistant/Associate who will work on applied and methodological research projects relating to interventions for obesity and prevention of diabetes and cardiovascular disease.  ScHARR, Regent Court Job Reference Number: UOS034891 Job Title: Research Assistant/Research Associate Contract Type: Fixed-term for 2 years Faculty: Faculty of Medicine Department: Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR) Salary: Grade 6: £28,762 - £33,314 per annum pro-rata. Potential to progress to £36 ..read more

Nancy Devlin Nancy Devlin, Clara Mukuria, Philip Powell, Tessa Peasgood The EQ Valuation Technology (EQ-VT) protocol has been widely used in the valuation of EuroQol instruments, including in over 25 national EQ-5D-5L value sets and, in an adapted form, the valuation of EQ-5D-Y-3L. Adapted versions of it are also currently being used for the valuation of EQ Health and Wellbeing (EQ-HWB). The depth of experience with using EQ-VT means that it represents a mature technology. However, as with any scientific endeavour, there is scope to strengthen existing approaches. The EuroQol Group is open to ..read more

Patient Reported Outcome Measures (PROMs) are tools (usually in a questionnaire format) that help to assess an individual’s mental health and wellbeing needs and measure change. Measuring outcomes can help clinicians and services better understand the impact of 1:1 interventions; ensure services are meeting the needs of different service users; and monitor and improve effectiveness, efficiency and quality of the service offered to its service users.  It is important as it helps to understand the benefit and impact people receive from their mental health ..read more

Data collection for the UK EQ-5D-5L valuation study to start in October 2022 Data collection for this key study to generate a UK value set for the EQ-5D-5L is due to start in October and will involve 1,200 interviews conducted in a representative sample of people living in England, Scotland, Northern Ireland and Wales. https://euroqol.org/ The launch of the new EQ-5D-5L valuation study for the United Kingdom was delayed due to the global COVID-19 pandemic. However, during this period extensive methodological work has been undertaken in preparation for the study. The study team has wor ..read more

New HEDS Discussion Paper - Value-adaptive clinical trial designs for efficient delivery of research – actions, opportunities and challenges for publicly funded trials Dr Laura Flight is the lead author on a new published HEDS Discussion Paper; 'Value-adaptive clinical trial designs for efficient delivery of research – actions, opportunities and challenges for publicly funded trials' HEDS Discussion Paper Series Abstract Value-adaptive designs are a set of emerging methods for efficient clinical trial design that aim to maximise expected population health for the money being spent. Th ..read more

We are currently advertising for two Research Assistants to join the Health Economics and Decision Science (HEDS) Section to provide support on a range of applied policy and methodological research. ScHARR, Regent Court Reference Number: UOS033854 Salary: Grade 6 Details: Part-time (17.5 hours per week) and fixed-term until September 2024 Closing Date: 3 August 2022    The vacancy and ATJ can be found can be found here.  You will work within the Health Economics and Decision Science (HEDS) Section (www.sh ..read more